Pfizer will sell nearly 500 vaccines and drugs at cost price to the poorest countries

Pfizer will sell nearly 500 vaccines and drugs at cost price to the poorest countries

Pfizer will sell nearly 500 vaccines and drugs at cost price to the poorest countries

US pharmaceutical giant Pfizer announced on Tuesday (January 17th) that it will sell nearly 500 of its vaccines and medicines at cost to poorer countries, expanding on a previous commitment to reduce global health inequalities.

>> Pfizer opens its medicine cabinet to the poorest countries

>> Pfizer boosted by sales of its vaccine and its anti-COVID pill

Pfizer’s COVID-19 vaccines.
Photo: AFP/VNA/CVN

In May 2022, the group had indicated, as part of an initiative announced at the Davos Economic Forum, that it would supply 23 of its vaccines and patented medicines available in the United States and the European Union to 45 poor countries. – the equivalent of 1.2 billion people.

Pfizer will now expand its offering under the agreement to include off-patent products, bringing the total of products offered from 23 to approximately 500.“, the company said in a statement.

These are all products for which Pfizer has worldwide rights, she said.

Selling at cost means that only manufacturing costs and transport expenses will be charged in the countries concerned.

Among the medicines and vaccines concerned, there are products “curing or preventing many of the greatest infectious and non-communicable disease threats facing low-income countries today“, such as antibiotics or chemotherapy, the company added.

We believe that this expansion of our product offering, combined with continued efforts to help address the barriers that limit or prevent access, will help us realize and even accelerate our vision of a world in which everyone world has access to the medicines and vaccines needed for a longer and healthier life“, said the CEO of Pfizer, Albert Bourla, quoted in the press release.

As Pfizer launches other drugs and vaccines, they will also be included in the agreement.

AFP/VNA/CVN

.